TipRanks
Go Ultimate55% OFF

Novartis (NVSN) Income Statement

Novartis Income Statement

Last quarter (Q3 2026), Novartis's total revenue was $15.03B, an increase of 4.67% from the same quarter last year. In Q3, Novartis's net income was $1.20B. See Novartis’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 54.81B$ 51.72B$ 46.66B$ 43.46B$ 43.97B
$ 41.12B$ 38.90B$ 34.19B$ 31.88B$ 32.24B
$ 24.05B$ 24.35B$ 24.42B$ 23.93B$ 22.18B
Depreciation and Amortization$ 5.35B$ 6.07B$ 8.28B$ 6.71B$ 5.60B
$ 22.99B$ 20.71B$ 18.25B$ 14.68B$ 30.91B
$ 17.07B$ 14.54B$ 9.77B$ 7.95B$ 10.06B
$ -638.25M$ -904.00M$ -646.00M$ -769.00M$ 14.47B
$ 16.44B$ 13.64B$ 9.12B$ 7.18B$ 24.53B
$ 14.06B$ 11.94B$ 14.85B$ 6.96B$ 24.02B
Per Share Metrics
Basic EPS$ 7.25$ 5.92$ 7.15$ 3.19$ 10.71
Diluted EPS$ 7.19$ 5.87$ 7.10$ 3.17$ 10.63
Weighted Average Shares Outstanding1.94B2.02B2.08B2.18B2.24B
Weighted Average Shares Outstanding (Diluted)1.96B2.04B2.09B2.20B2.26B

Currency in USD

Novartis Earnings and Revenue History

020B40B60B0 %20 %40 %60 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin